Coronary heart disease in China
Coronary heart disease in China
复制标题
DOI：
10.1136/hrt.2007.132423
复制
发表时间：
2008-09-01
期刊：
影响因子：
5.7
通讯作者：
Liu, L.
中科院分区：
文献类型：
--
作者：
Zhang, X-H;Lu, Z. L.;Liu, L.
冠心病是中国人群心血管疾病死亡的第二大原因。它占城市地区心血管死亡人数的22%，农村地区为13%。虽然中国冠心病的死亡率与西方国家相比相对较低，但冠心病的负担一直在增加。部分原因是风险因素的恶化，如高血压、高血脂、超重/肥胖、糖尿病等的流行率增加，部分原因是老年人口的增加。已对中国心肌梗死患者进行了溶栓、降压、抗血小板和降血脂治疗以及心脏介入治疗的大规模随机对照试验。这些研究为中国人群中慢性CHD和急性心肌梗死的预防和管理提供了重要信息。
Coronary heart disease (CHD) is the second leading cause of cardiovascular death in the Chinese population. It accounts for 22% of cardiovascular deaths in urban areas and 13% in rural areas. Although mortality from CHD in China is relatively low compared with Western levels, the burden of CHD has been increasing. This is partly because of a worsening profile of risk factors, such as an increased prevalence of hypertension, hyperlipidaemia, overweight/obesity, diabetes, etc and partly because of an increase in the aged population. Large-scale, randomised controlled trials on thrombolytic, blood-pressure-lowering, antiplatelet and blood-cholesterol-lowering treatment as well as cardiac intervention have been conducted for Chinese patients with myocardial infarction. The studies provide important information for the prevention and management of chronic CHD and acute myocardial infarction in the Chinese population.